Venomics AI Raises $2.7M Pre-seed
Venomics AI raises $2.7M in a pre-seed round co-led by Speciale Invest and South Park Commons to advance its AI-powered venom-based drug discovery platform.
Venomics AI Raises $2.7M Pre-seed
Venomics AI, a Bengaluru, India-based startup that develops AI-powered platforms for drug discovery, has raised $2.7 million in a pre-seed funding round. The investment will support the company as it advances its work in computational biology and therapeutic research.
Investors
The round was co-led by Speciale Invest and South Park Commons, with participation from Operators Studio.
Venomics AI Use of Funds
The company intends to use the capital to expand its operations and accelerate its product development efforts.
About Venomics AI
Founded in 2026 as a spin-out from the Indian Institute of Science, Venomics AI is led by Sunagar and Vinay Prabhu. The company focuses on building AI-driven platforms for venom-based drug discovery, integrating artificial intelligence with computational biology and experimental science to accelerate the development of next-generation therapeutics.
Funding Details
Company Website: https://venomics.ai
Company: Venomics AI
Raised: $2.7M
Round: Pre-seed
Funding Date: November 9, 2026
Lead Investor: Speciale Invest, South Park Commons
Additional Investors: Operators Studio
Software Category: Biotech AI
Source: https://www.finsmes.com/2026/11/venomics-ai-raises-2-7m-in-pre-seed-funding.html